Capecitabine‐containing regimens vs non‐capecitabine‐containing regimens or no chemotherapy
Overall survival: Median length of · patients with early breast cancer
Capecitabine‐containing regimens probably leads to lower overall survival (OS)median compared with non‐capecitabine‐containing regimens or no chemotherapy (moderate certainty).
1 finding from 1 review
- Capecitabine for hormone receptor‐positive versus hormone receptor‐negative breast cancer 2021 · Cochrane Headline outcomes onlyHR 0.89 [0.81, 0.98]8 studies · 13547 participantsModerate